Skip to main content

Table 2 Subgroup analyses of overall graft failure associated with HLA per mismatch and HLA-DR mismatches

From: What is the impact of human leukocyte antigen mismatching on graft survival and mortality in renal transplantation? A meta-analysis of 23 cohort studies involving 486,608 recipients

 

HLA per mismatch

HLA-DR mismatches

Subgroup

No. of recipients (cohorts)

HR (95% CI)

I 2

P a

No. of recipients (cohorts)

HR (95% CI)

I 2

P a

Sample size

   

0.835

   

0.011

 ≥10,000

281,141 (5)

1.06 (1.05–1.07)

49.1

 

145,351 (2)

1.07 (1.04–1.10)

0

 

 < 10,000

8614 (7)

1.06 (1.03–1.09)

17.3

 

4652 (5)

1.27 (1.12–1.43)

48.4

 

Nature of data

   

0.133

   

0.076

 Univariable-unadjusted

1440 (4)

1.14 (1.04–1.26)

24.8

 

2598 (2)

1.39 (1.05–1.83)

70.0

 

 Multivariable-adjusted

286,755 (12)

1.06 (1.05–1.07)

27.4

 

150,003 (7)

1.08 (1.05–1.11)

58.3

 

Data source

   

0.683

   

0.011

 Registry/Multi-center

286,283 (6)

1.06 (1.05–1.07)

38.9

 

145,351 (2)

1.07 (1.04–1.10)

0

 

 Single-center

3472 (6)

1.07 (1.02–1.12)

26.6

 

4652 (5)

1.27 (1.12–1.43)

48.4

 

Donor source

   

0.027

   

0.616

 Cadaveric

138,516 (5)

1.07 (1.06–1.07)

0.00

 

41,284 (5)

1.08 (1.04–1.11)

66.4

 

 Living and Cadaveric

151,239 (7)

1.05 (1.05–1.06)

16.4

 

108,719 (2)

1.09 (1.04–1.15)

55.4

 

 Geographical locations

   

0.053

   

0.033

 Europe

138,988 (6)

1.07 (1.06–1.08)

0.00

 

1952 (4)

1.32 (1.09–1.60)

59.7

 

 North America

137,880 (4)

1.05 (1.04–1.06)

2.1

 

145,351 (2)

1.07 (1.04–1.10)

0

 

 Asia

225 (1)

1.24 (1.00–1.55)

–

 

2700 (1)

1.23 (1.05–1.45)

–

 

 Oceania

12,662 (1)

1.07 (1.03–1.12)

–

 

0

–

–

 

Year period

   

0.175

   

0.026

 Prior to 1995

103,915 (6)

1.06 (1.05–1.07)

0.00

 

148,051 (3)

1.08 (1.04–1.12)

26.8

 

 Not prior to 1995

185,626(5)

1.06 (1.05–1.08)

60.1

 

4054 (4)

1.36 (0.98–1.88)

59.7

 

 NR

214 (1)

0.83 (0.51–1.34)

–

–

–

–

–

–

  1. The effect estimates were stratified for sample size (≥10,000 vs < 10,000), data source (multi-centered vs single-centered), donor source (cadaveric vs living and cadaveric), geographic locations (European, North America, Asia and Oceania) and year period (prior to 1995 vs not prior to 1995)
  2. aP value for heterogeneity